Management of common adverse effects of antipsychotic medications

TS Stroup, N Gray - World Psychiatry, 2018 - Wiley Online Library
The benefits of antipsychotic medications are sometimes obscured by their adverse effects.
These effects range from relatively minor tolerability issues (eg, mild sedation or dry mouth) …

Neuroleptic malignant syndrome: a review from a clinically oriented perspective

L Tse, AM Barr, V Scarapicchia… - Current …, 2015 - ingentaconnect.com
Neuroleptic malignant syndrome (NMS) is a rare but potentially life-threatening sideeffect
that can occur in response to treatment with antipsychotic drugs. Symptoms commonly …

[HTML][HTML] An update on tardive dyskinesia: from phenomenology to treatment

O Waln, J Jankovic - Tremor and other hyperkinetic movements, 2013 - ncbi.nlm.nih.gov
Tardive dyskinesia (TD), characterized by oro-buccal-lingual stereotypy, can manifest in the
form of akathisia, dystonia, tics, tremor, chorea, or as a combination of different types of …

Second-generation antipsychotics and neuroleptic malignant syndrome: systematic review and case report analysis

M Belvederi Murri, A Guaglianone, M Bugliani… - Drugs in R&D, 2015 - Springer
Background Neuroleptic malignant syndrome (NMS) is a rare, severe, idiosyncratic adverse
reaction to antipsychotics. Second-generation antipsychotics (SGAs) were originally …

Clinical determinants of fever in clozapine users and implications for treatment management: a narrative review

H Verdoux, C Quiles, J de Leon - Schizophrenia Research, 2019 - Elsevier
Objectives To identify the clinical determinants of fever in clozapine users and their impact
on management of clozapine treatment. Methods Articles published in English or French …

Antioxidant properties of second-generation antipsychotics: Focus on microglia

G Caruso, M Grasso, A Fidilio, F Tascedda, F Drago… - Pharmaceuticals, 2020 - mdpi.com
Recent studies suggest a primary role of oxidative stress in an early phase of the
pathogenesis of schizophrenia and a strong neurobiological link has been found between …

Acute and subacute drug-induced movement disorders

PR Burkhard - Parkinsonism & related disorders, 2014 - Elsevier
Many pharmacological agents may induce a variety of movement disorders, including
dystonia, tremor, parkinsonism, myoclonus and dyskinesia, with an acute, subacute or more …

Movement disorders emergencies

S Rajan, B Kaas, E Moukheiber - Seminars in neurology, 2019 - thieme-connect.com
Many acute and potentially life-threatening medical conditions have hyperkinetic or
hypokinetic movement disorders as their hallmark. Here we review the clinical …

A systematic review of sex and age factors in neuroleptic malignant syndrome diagnosis frequency

RJ Gurrera - Acta Psychiatrica Scandinavica, 2017 - Wiley Online Library
Objective To examine sex and age distributions in neuroleptic malignant syndrome (NMS)
patients based on a systematic literature review. Method EMBASE and PubMed databases …

Antipsychotic dose escalation as a trigger for neuroleptic malignant syndrome (NMS): literature review and case series report

J Langan, D Martin, P Shajahan, DJ Smith - BMC psychiatry, 2012 - Springer
Background “Neuroleptic malignant syndrome”(NMS) is a potentially fatal idiosyncratic
reaction to any medication which affects the central dopaminergic system. Between 0.5 …